Sofinnova Partners
Venture Capital · Biotechnology

Sofinnova Partners portfolio

Sofinnova Partners (Venture capital) is known to hold 131 companies, 61 of them startups. 20 of them are hiring now, with 924 open roles. In the last 12 months rounds in the press named it 1 times (1 as the lead). Its companies closed 15 venture rounds in 12 months, raising $446.2M. Most of them work in Health Care, Biotechnology, Food & Beverages.

Source: Alion Venture capital Nov 20, 2026
Investments
131
61 of them startups
Hiring now
20
924 open roles
Deals in 12 months
1
1 as the lead
Rounds in 12 months
15
$446.2M raised
Exits
19

Companies Sofinnova Partners has invested in

Galvanize Therapeutics® Inc Surgical Instruments & Devices · United States Venture round $136.2M · this month 9 roles portfolio pageSep 25
EnginZyme Industrial Biotechnology · Sweden Venture round $7.1M · 1 mo ago lead 2 roles portfolio page, round in the pressApr 22, 2020
F2G. United Kingdom Venture round · 1 mo ago portfolio pageSep 25
HighLife Medical Cardiovascular Devices Venture round $90M · 1 mo ago portfolio pageSep 25
Mironid Series B $43.1M · 3 mo ago portfolio pageSep 25
Cellucomp Venture round · 4 mo ago portfolio pageSep 25
TISSIUM Plastics & Polymers · France Venture round $64.8M · 4 mo ago portfolio pageOct 2
Ingenix AI for Science Seed $14M · 5 mo ago lead portfolio page, round in the pressJun 3
Synthace Higher Education Venture round · 6 mo ago portfolio pageOct 2
GenSight Biologics Cell & Gene Therapy Venture round $1.8M · 8 mo ago portfolio pageSep 25
May Health France Venture round $11.7M · 8 mo ago portfolio pageSep 25
Mediar Therapeutics Series B $76M · 10 mo ago portfolio pageSep 25
DMC Biotechnologies Brewing & Beer · United States Venture round $1.4M · 11 mo ago portfolio pageSep 25
DISCO Pharmaceuticals GmbH Oncology Therapeutics · Germany Venture round · 11 mo ago portfolio pageSep 25
Qorium Venture round $23.8M · 12 mo ago portfolio pageOct 2
AAVantgarde Rare Disease Therapeutics · Italy Series B $141M · 12 mo ago 1 role portfolio pageSep 25
Latent Labs Drug Discovery · United Kingdom Venture round · 12 mo ago 6 roles portfolio pageSep 25
Hemab Venture round $157M · 12 mo ago portfolio pageSep 25
Elevara Medicines Immunology & Inflammation Therapeutics Series A $70M · 12 mo ago portfolio pageSep 25
Arzeda Synthetic Biology Venture round $4.5M · 14 mo ago 1 role portfolio pageSep 25
SafeHeal Series C $37.8M · 18 mo ago portfolio pageOct 2
Bioptimus Foundation Models · France Venture round $41M · 22 mo ago 2 roles portfolio pageSep 25
Elicit Plant Food Technology Series B $48.6M · 2 yr ago portfolio pageSep 25
Noema Pharma Drug Discovery · Switzerland Series B · 2 yr ago 1 role portfolio page, round in the pressNov 12, 2024
Genespire Series B $50.3M · 2 yr ago lead portfolio page, round in the pressSep 25, 2024
Asceneuron Series C $100M · 2 yr ago portfolio pageSep 25
Cure51 Drug Discovery AI · France Seed $16.2M · 2 yr ago portfolio pageSep 25
Mainstay Medical Neurotech & Neuromodulation · United States Venture round $125M · 2 yr ago 6 roles portfolio pageSep 25
RefleXion Cancer Care Centers · United States Venture round $106.7M · 3 yr ago portfolio pageOct 2
CorWave Cardiovascular Devices · France Series C $65.9M · 3 yr ago 6 roles portfolio pageSep 25
Alia therapeutics Cell & Gene Therapy · Italy Seed $4.8M · 3 yr ago lead portfolio page, round in the pressApr 17, 2023
Deepc Medical AI · Germany Series A $13M · 3 yr ago portfolio pageSep 25
BioCorteX Drug Discovery Venture round $5M · 3 yr ago lead portfolio page, round in the pressMar 27, 2023
Inspirna Oncology Therapeutics · United States Series D $55.1M · 4 yr ago portfolio pageSep 25
GFBiochemicals Vegan Food Series A $16.2M · 4 yr ago lead round in the pressMay 5, 2022
LimFlow France Series D $40M · 4 yr ago portfolio pageSep 25
Prometheus Materials United States Venture round $4.1M · 4 yr ago portfolio pageSep 25
Verona Pharma Venture round $200.2M · 6 yr ago portfolio pageOct 2
CorVent Medical Respiratory & Sleep Devices · United States Seed $4.5M · 6 yr ago portfolio pageSep 25
Pi-Cardia Cardiovascular Devices Venture round $27M · 6 yr ago lead portfolio page, round in the pressApr 19, 2020
P2Science Venture round $15.6M · 7 yr ago portfolio pageSep 25
microphyt Food Biotechnology Venture round $30.8M · 7 yr ago lead portfolio page, round in the pressJul 9, 2019
Hookipapharma Venture round $37.4M · 7 yr ago portfolio pageSep 25
Shockwave Medical Cardiovascular Devices · United States Venture round $15M · 7 yr ago 1 role portfolio pageOct 2
MaxCyte Cell & Gene Therapy · United States Venture round $760k · 10 yr ago 2 roles portfolio pageSep 25
Medtronic Cardiovascular Devices · Ireland 821 roles portfolio pageSep 25
Ascendis Pharma Prescription Drugs · Denmark 34 roles portfolio pageSep 25
DBV Technologies Immunology & Inflammation Therapeutics 15 roles portfolio pageSep 25
Tenpoint Therapeutics Prescription Drugs · United States 12 roles portfolio pageOct 2
Recor Medical Health & Medical Electronics · United States 10 roles portfolio pageOct 2
Avantium Chemical Manufacturing · Netherlands 2 roles portfolio pageSep 25
Ironwood Pharmaceuticals APIs & Drug Manufacturing · United States 2 roles portfolio pageOct 2
GlycoEra Synthetic Biology · Switzerland 1 role portfolio pageSep 25
Micropep Agricultural Biotechnology · France 2 roles portfolio pageSep 25
90Phutzac Sports Media portfolio pageSep 25
Abivax | Immunology & Inflammation Therapeutics · France portfolio pageSep 25
Actithera Oncology Therapeutics portfolio pageSep 25
AFYREN Bioenergy · France portfolio pageSep 25
Bionyra Pharma Biologics & Biosimilars portfolio pageSep 25
Biosyntia Denmark portfolio pageSep 25
Biotalys Crop Protection portfolio pageSep 25
Borea Therapeutics Cell & Gene Therapy portfolio pageSep 25
Calliditas Therapeutics AB Biologics & Biosimilars portfolio pageSep 25
Cell Centric United Kingdom portfolio pageSep 25
Chroma Bio, Inc. United States portfolio pageSep 25
Cometbio Microbiome portfolio pageSep 25
DNA Script Genomics & Genetic Testing · France portfolio pageSep 25
Excelsiorsci Drug Discovery portfolio pageSep 25
GFBiochemicals SAS Chemical Engineering portfolio pageSep 25
HAYA Therapeutics Drug Discovery portfolio pageSep 25
HeartRecovery Job Boards & Aggregators portfolio pageSep 25
IMIO Industrial Biotechnology portfolio pageOct 25
Inventiva Cardiometabolic Therapeutics portfolio pageSep 25
iOmx Therapeutics Drug Discovery portfolio pageSep 25
Kiro Medical AI · France portfolio pageSep 25
Meiogenix Synthetic Biology portfolio pageSep 25
Metgen Industrial Biotechnology portfolio pageSep 25
12

Focus

Markets
Health Care45%
Biotechnology41%
Food & Beverages13%
Artificial Intelligence9%
Energy & Utilities4%
Manufacturing4%
Farming & Agriculture4%
Consumer Electronics4%
Where its companies are
France11%
United States10%
United Kingdom3%
Italy2%
Denmark2%
Netherlands2%
Germany2%
Switzerland2%
Stage of its companies
Series B44%
Series A33%
Pre-seed & seed22%

Questions about Sofinnova Partners

How many companies has Sofinnova Partners invested in?

Sofinnova Partners is known to hold 131 companies: 61 startups, and 19 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Sofinnova Partners investing now?

Yes: in the last 12 months 1 rounds in the press named Sofinnova Partners (1 as the lead), and 3 companies joined its portfolio page in 90 days.

What does Sofinnova Partners invest in?

The markets of the companies Sofinnova Partners holds: Health Care (45%), Biotechnology (41%), Food & Beverages (13%), Artificial Intelligence (9%), Energy & Utilities (4%).

Which Sofinnova Partners portfolio companies are hiring?

20 companies Sofinnova Partners holds are hiring now, with 924 open roles listed on this page.

Who does Sofinnova Partners invest alongside?

The investors that hold the most companies together with Sofinnova Partners: Omega Funds, M Ventures, Kurma Partners, Sofinnova Investments, NEA.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Nov 8; 10 rounds in the press that name it

Sofinnova Partners portfolio: 131 known companies. Alion, Nov 20, 2026. https://alion.io/company/sofinnova-partners/portfolio

Licence: CC BY-SA 4.0JSON